Abstract
The incidence of allergic diseases over the past few decades has shown a significant increase. Many epidemiological studies have shown that dietary factors are involved in the occurrence and development of allergic diseases, especially in early childhood. Hypotheses on the occurrence of a variety of allergic diseases (immunological mechanism) have provided a theoretical basis for dietary interventions for allergic diseases. However, currently, there are still inconsistencies among results of randomized controlled trials (RCTs). Epidemiological and immunological studies have been inconsistent, and in some cases, the results even directly contradict each other. In certain populations, dietary interventions have shown promising signs. Due to the complexity of the pathogenesis of allergic diseases, the issue of whether dietary interventions can prevent the development and progression of allergic disease requires collaborative work among clinicians, epidemiologists, immunologists, and geneticists. Ideally, this will identify population subgroups that would benefit the most from dietary intervention. The individuals in those populations could then be screened. These results may facilitate the development of individualized dietary interventions.
Keywords: Allergic diseases, dietary, intervention, immunology, epidemiology, clinic trials.
Current Pharmaceutical Design
Title:Dietary Intervention for Allergic Disease
Volume: 20 Issue: 6
Author(s): Yi Huang, Guansong Wang and Changzheng Wang
Affiliation:
Keywords: Allergic diseases, dietary, intervention, immunology, epidemiology, clinic trials.
Abstract: The incidence of allergic diseases over the past few decades has shown a significant increase. Many epidemiological studies have shown that dietary factors are involved in the occurrence and development of allergic diseases, especially in early childhood. Hypotheses on the occurrence of a variety of allergic diseases (immunological mechanism) have provided a theoretical basis for dietary interventions for allergic diseases. However, currently, there are still inconsistencies among results of randomized controlled trials (RCTs). Epidemiological and immunological studies have been inconsistent, and in some cases, the results even directly contradict each other. In certain populations, dietary interventions have shown promising signs. Due to the complexity of the pathogenesis of allergic diseases, the issue of whether dietary interventions can prevent the development and progression of allergic disease requires collaborative work among clinicians, epidemiologists, immunologists, and geneticists. Ideally, this will identify population subgroups that would benefit the most from dietary intervention. The individuals in those populations could then be screened. These results may facilitate the development of individualized dietary interventions.
Export Options
About this article
Cite this article as:
Huang Yi, Wang Guansong and Wang Changzheng, Dietary Intervention for Allergic Disease, Current Pharmaceutical Design 2014; 20 (6) . https://dx.doi.org/10.2174/13816128113199990049
DOI https://dx.doi.org/10.2174/13816128113199990049 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Combination Therapy of Statins with Ezetimibe
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Coronary Pressure Measurement Based Decision Making for Percutaneous Coronary Intervention
Current Cardiology Reviews Hypolipidaemic Drug Treatment: Yesterday is Not Gone Yet, Today is Challenging and Tomorrow is Coming Soon; let us Combine them all
Current Pharmaceutical Design Unfolded Protein Response as a Therapeutic Target in Cardiovascular Disease
Current Topics in Medicinal Chemistry Actions of Adjunctive Nutritional Antioxidants in Periodontitis and Prevalent Systemic Inflammatory Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Histone Deacetylase Inhibitors and Colorectal Cancer: what is new?
Anti-Cancer Agents in Medicinal Chemistry The Applications of Pharmacogenomics to Neurological Disorders
Current Molecular Medicine Mechanisms of Thrombosis, Available Treatments and Management Challenges Presented by Thromboangiitis Obliterans
Current Medicinal Chemistry Design, Synthesis and ex vivo Study of the Vasorelaxant Activity Induced by Isosteric Derivatives of Dihydropyridines (NH→O)
Letters in Drug Design & Discovery Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
Current Pharmaceutical Design Association Between Heart Rate Variability and Parkinson’s Disease: A Meta-analysis
Current Pharmaceutical Design Nitric Oxide as a Marker for Levo-Thyroxine Therapy in Subclinical Hypothyroid Patients
Current Vascular Pharmacology Editorial [Hot Topic:Nicotinamide Adenine Dinucleotide Biology and Disease(Executive Editor: W. Todd Penberthy)]
Current Pharmaceutical Design Diuretic-Associated Electrolyte Disorders in the Elderly: Risk Factors, Impact, Management and Prevention
Current Drug Safety Carvedilol: Just Another Beta-Blocker or a Powerful Cardioprotector?
Cardiovascular & Hematological Disorders-Drug Targets Implications of microRNAs in the Pathogenesis of Atherosclerosis and Prospects for Therapy
Current Drug Targets Overview of Green Tea Interaction with Cardiovascular Drugs
Current Pharmaceutical Design Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
Current Pharmaceutical Design Determinants of 25-Hydroxyvitamin D Concentrations in Infants and Toddlers
Current Nutrition & Food Science Therapeutic Challenges in Neuroendocrine Tumors
Anti-Cancer Agents in Medicinal Chemistry